Mostrando
1
al
20
de
59
resultados
AgroServ: Integrated SERvices supporting a sustainable AGROecological transition
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
participó en un
HORIZON EUROPE:
HORIZON-INFRA-2021-SERV-01
Developing a resilient and sustainable agriculture system, and the agroecological transitions requires a deep understanding of agroecosystem...
2022-06-17 - 2027-08-31 | Financiado
2022-06-17 - 2027-08-31 | Financiado
ISIDORe: Integrated Services for Infectious Disease Outbreak Research
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
participó en un
HORIZON EUROPE:
HORIZON-INFRA-2021-EMERGENCY-02
The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado
2022-02-09 - 2025-07-31 | Financiado
EUGLOHRIA: THE EUROPEAN ALLIANCE FOR GLOBAL HEALTH TRANSFORMATION THROUGH JOINT RESEARCH AND INNOVATION ACTIO...
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
participó en un
H2020:
As one of 17 selected pilot European Universities, the European Alliance for Global Health (EUGLOH) and its five partner institutions (UPSac...
2020-11-26 - 2023-12-31 | Financiado
2020-11-26 - 2023-12-31 | Financiado
PhasAGE: Excellence Hub on Phase Transitions in Aging and Age Related Disorders
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
tramitó un
H2020:
H2020-WIDESPREAD-2018-2020
The percentage of elderly population in Portugal and Europe is in rapid expansion raising a pressing concern for the increase of seriously i...
2020-07-02 - 2024-03-31 | Financiado
2020-07-02 - 2024-03-31 | Financiado
ImmunoHUB: An Immunological Hub of Excellence in Porto tailored to fulfil the ERA Priorities
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
tramitó un
H2020:
H2020-WIDESPREAD-2018-2020
The mission of an ERA Chair in Immunology (ImmunoHUB) is to create a Platform of excellence in research and innovation at IBMC-i3S (Portugal...
2020-06-10 - 2026-12-31 | Financiado
2020-06-10 - 2026-12-31 | Financiado
NCBio: Unlocking excellence in research and innovation in neurobiology and neurological disorders at IBMC I...
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
tramitó un
H2020:
H2020-WIDESPREAD-2018-2020
Our limited understanding of the cellular and molecular basis of the Nervous System, together with the divergent and complex traits of Neuro...
2020-06-10 - 2026-12-31 | Financiado
2020-06-10 - 2026-12-31 | Financiado
REMODEL: Research models in infection cancer and regeneration replacement and translation
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
tramitó un
H2020:
H2020-WIDESPREAD-2018-2020
REMODEL combines the existing local expertise in bioengineering, cancer and infectious diseases with partners at the frontline in developing...
2019-07-09 - 2023-04-30 | Financiado
2019-07-09 - 2023-04-30 | Financiado
NEUROTWIN: Pan European twinning to re establish world level Neuroscience Centre in Kiev NEUROTWIN
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
participó en un
H2020:
H2020-WIDESPREAD-2018-2020
The overarching goal of the NEUROTWIN proposal is to re-establish the Bogomoletz Institute of Physiology (BIPH) in Kiev, Ukraine as an inter...
2019-07-02 - 2022-07-31 | Financiado
2019-07-02 - 2022-07-31 | Financiado
EU-OPENSCREEN-DRIVE: Ensuring long term sustainability of excellence in chemical biology within Europe and beyond
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
participó en un
H2020:
H2020-INFRADEV-2018-2020
EU-OPENSCREEN (EU-OS), the European Research Infrastructure of Open Screening Platforms for Chemical Biology, builds a distributed organizat...
2018-12-13 - 2023-10-31 | Financiado
2018-12-13 - 2023-10-31 | Financiado
INTEGRITY: INTEGRITY empowering students through evidence based scaffolded learning of Responsible Conduct in...
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
participó en un
H2020:
H2020-SwafS-2018-2020
INTEGRITY’s innovative approach aims to empower students in responsible research: using RCR INTEGRITY will build a teaching philosophy that...
2018-11-28 - 2022-06-30 | Financiado
2018-11-28 - 2022-06-30 | Financiado
IMI-PainCare: Improving the care of patients suffering from acute or chronic pain
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
participó en un
H2020:
H2020-JTI-IMI2-2016-10-two-stage
There is a very high need for improving the management of pain. Acute and persistent pain of different origins represent a common medical, s...
2018-05-04 - 2023-03-31 | Financiado
2018-05-04 - 2023-03-31 | Financiado
IMGENE: Improving Genome Editing Efficiency IMGENE
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
participó en un
H2020:
H2020-MSCA-ITN-2017
CRISPR genome editing technology is considered to become the greatest technological improvement in biomedical research since the invention o...
2017-07-18 - 2021-08-31 | Financiado
2017-07-18 - 2021-08-31 | Financiado
ChromoDrive: Investigating how anaphase chromosomal motion is generated during mitosis and meiosis
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
tramitó un
H2020:
H2020-MSCA-IF-2016
Cell division is a process essential for life. There are two types of cell division: meiosis and mitosis. Meiosis is a type of cell division...
2017-03-16 - 2019-06-30 | Financiado
2017-03-16 - 2019-06-30 | Financiado
CODECHECK: CRACKING THE CODE BEHIND MITOTIC FIDELITY the roles of tubulin post translational modifications and...
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC
tramitó un
H2020:
ERC-2015-CoG
During the human lifetime 10000 trillion cell divisions take place to ensure tissue homeostasis and several vital functions in the organism....
2016-07-19 - 2023-06-30 | Financiado
2016-07-19 - 2023-06-30 | Financiado
* No se disponen de datos de la empresa actual.